Transcode Therapeutics, Inc. (RNAZ) stock
RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.41+0.06 (+4.44%)
Close on Nov 17, 2026Market cap $1.43MP/E –Yield –
Transcode Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Transcode Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.61M. For fiscal 2025 it was -$19.52M. The highest annual figure on record is -$492.97K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.52M | – |
| FY2024 | Dec 31, 2024 | -$13.34M | – |
| FY2023 | Dec 31, 2023 | -$18.07M | – |
| FY2022 | Dec 31, 2022 | -$15.76M | – |
| FY2021 | Dec 31, 2021 | -$5.27M | – |
| FY2020 | Dec 31, 2020 | -$492.97K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.08M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.91M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.94M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.66M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.51M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.51M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.02M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.60M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$76.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$522.15K | – |
| Q4 FY2020 | Dec 31, 2020 | -$255.49K | – |
| Q3 FY2020 | Sep 30, 2020 | -$130.84K | – |
See a number that looks wrong?